| Product Code: ETC7659056 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Phosphodiesterase (PDE) Inhibitors Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Phosphodiesterase (PDE) Inhibitors Market - Industry Life Cycle |
3.4 Israel Phosphodiesterase (PDE) Inhibitors Market - Porter's Five Forces |
3.5 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Phosphodiesterase (PDE) Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of erectile dysfunction and other related disorders in Israel |
4.2.2 Growing geriatric population in Israel leading to higher demand for phosphodiesterase inhibitors |
4.2.3 Technological advancements in drug delivery systems improving the efficacy and safety of PDE inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 Rising competition from alternative treatment options such as herbal supplements or lifestyle changes |
5 Israel Phosphodiesterase (PDE) Inhibitors Market Trends |
6 Israel Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1 Israel Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specific, 2021- 2031F |
6.1.4 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Non-Specific, 2021- 2031F |
6.1.5 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Phosphodiesterase (PDE) Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.3 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Erectile Dysfunction, 2021- 2031F |
6.2.4 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Inflammatory Airways Disease, 2021- 2031F |
6.2.5 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Phosphodiesterase (PDE) Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Phosphodiesterase (PDE) Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Phosphodiesterase (PDE) Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Phosphodiesterase (PDE) Inhibitors Market Import-Export Trade Statistics |
7.1 Israel Phosphodiesterase (PDE) Inhibitors Market Export to Major Countries |
7.2 Israel Phosphodiesterase (PDE) Inhibitors Market Imports from Major Countries |
8 Israel Phosphodiesterase (PDE) Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials conducted for new PDE inhibitors in Israel |
8.2 Adoption rate of PDE inhibitors among healthcare providers in Israel |
8.3 Patient satisfaction and compliance rates with PDE inhibitor therapies |
9 Israel Phosphodiesterase (PDE) Inhibitors Market - Opportunity Assessment |
9.1 Israel Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Israel Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Phosphodiesterase (PDE) Inhibitors Market - Competitive Landscape |
10.1 Israel Phosphodiesterase (PDE) Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Israel Phosphodiesterase (PDE) Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here